Who are we?

StatisticaMedica Ltd. is a leading European clinical research organization that specialises in the design and implementation, analysis and reporting of clinical trials in the  pharmaceutical, medical device, diagnostics, food and healthcare industries. 

 
 
 

Testimonials

  • The advice is invaluable, providing clear thought provoking guidance in the design of studies as well as in the interpretation of results

    Professor of Respiratory Medicine, Beaumont Hospital, Dublin Ireland
  • StatisticaMedica has provided our research group with invaluable guidance and assistance with our varied projects, from randomised controlled trials through to biomedical research. We have benefited fundamentally by seeking their input at the conceptual stages of our research, because they offer far more than basic statistical support – our research design, methodology and, indeed, the strategic development of our group has been augmented by our association with StatisticaMedica. 

    Prof. of Paediatric Emergency Medicine, Cork University Hospital, Ireland
  • StatisticaMedica have provided extensive expertise in clinical investigation planning including selection of study variables, inclusion/exclusion criteria and SOP development. They have provided tailored in house training on clinical investigation plan design and execution in accordance with OECD GLP and ISO 14155 guidelines. StatisticaMedica continues to be a vital resource for our company. StatisticaMedica are a responsive, well-informed statistical consultancy solution 

    Clinical Research Manager, Medical Device Company, UK
  • StatisticaMedica provides added value with their in-depth knowledge of the European clinical market, clinical study design and statistics and their network of Irish and European experts 

    Centre Director from a leading Research Institute, USA
  • Gloria, Let me thank you and StatisticaMedica for the work you did for Kitov Pharmaceuticals.  Your prompt and efficient analysis of our phase 3 clinical data were essential in the successful outcome of our study.

    J. Paul Waymack M.D., Sc.D. Chairman of the Board Kitov Pharmaceuticals